Trademark Trial and Appeal Board Electronic Filing System. https://estta.uspto.gov
`ESTTA Tracking number:
`ESTTA1216998
`06/22/2022
`
`Filing date:
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Notice of Opposition
`
`Notice is hereby given that the following party opposes registration of the indicated application.
`Opposer information
`
`Name
`Entity
`Address
`
`Attorney informa-
`tion
`
`Docket no.
`
`Lonza Ltd.
`Corporation
`LONZASTRASSE
`VISP, 3930
`SWITZERLAND
`
`Citizenship
`
`Switzerland
`
`LAWRENCE J. CRAIN
`GREER, BURNS & CRAIN LTD.
`300 SOUTH WACKER DRIVE, SUITE 2500
`CHICAGO, IL 60606
`UNITED STATES
`Primary email: lcrain@gbc.law
`Secondary email(s): amartin@gb.law, tmdocket@gbc.law
`312-360-0080
`5335.125700
`
`Applicant information
`
`Application no.
`Opposition filing
`date
`Applicant
`
`87404854
`06/22/2022
`
`Publication date
`Opposition period
`ends
`
`05/24/2022
`06/23/2022
`
`Novartis AG
`CH-4002
`BASEL
`SWITZERLAND
`Goods/services affected by opposition
`
`Class 005. First Use: None First Use In Commerce: None
`All goods and services in the class are opposed, namely: Anti-infectives; Anti-inflammatories; Anti-
`bacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharma-
`ceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the pre-
`vention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on
`the central nervous system; Pharmaceutical preparations and substances for the prevention and
`treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment
`of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system,
`the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in
`hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention
`and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and
`treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of
`immune system related diseases and disorders; Pharmaceutical preparations for the prevention an-
`dtreatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of dia-
`betes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical
`preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use
`
`

`

`in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthal-
`mological use; Pharmaceutical products forthe prevention and treatment of cancer and tumors; Phar-
`maceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for
`the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treat-
`ment of respiratory diseases and asthma
`
`Grounds for opposition
`
`Priority and likelihood of confusion
`Dilution by blurring
`
`Trademark Act Section 2(d)
`Trademark Act Sections 2 and 43(c)
`
`Marks cited by opposer as basis for opposition
`
`U.S. registration
`no.
`Register
`Registration date
`
`956300
`
`Principal
`04/03/1973
`
`Application date
`
`12/22/1969
`
`Foreign priority
`date
`
`NONE
`
`Word mark
`Design mark
`Description of
`mark
`Goods/services
`
`LONZA
`
`NONE
`
`Class 001. First use: First Use: Feb 1926 First Use In Commerce: Jul 1926
`ADHESIVE SUBSTANCES USED IN INDUSTRY; INORGANIC AND ORGANIC
`SALTS; ACIDS; BASES; SATURATED AND UNSATURATED ALIPHATIC HY-
`DROCARBONS; PARAFFINES; AROMATIC HYDROCARBONS; ORGANIC
`OXYGEN COMPOUNDS SUCH AS MONOVALENT AND MULTIVALENT AL-
`COHOLATES, ESTERS, KETONES, ALDEHYDES, ETHERS, CARBOXYLIC
`ACIDS, ANHYDRIDES, HYDROXYACIDS, KETO COMPOUNDS, HALOGEN-
`ATED FATTY ACIDS,ORGANIC NITROGEN COMPOUNDS, NITRILES,
`AMINES, AMIDES, NITRO COMPOUNDS, CYCLIC COMPOUNDS, HETERO-
`CYCLIC COMPOUNDS, AND COMPOUNDS CONTAINING HETEROATOMS,
`ORGANO METALIC COMPOUNDS, INORGANIC COMPOUNDS, CARBIDES,
`NITRIDES, OXIDES, SILICIDES, BORIDES, PHOSPHATES, PHOSPHINES,
`SILICATES, INORGANIC PRODUCTS CONTAINING HALOGEN AND SUL-
`PHUR; INORGANIC STARTING, INTERMEDIATE, OR AUXILIARY
`PRODUCTS FOR CHEMICAL AND CERAMIC PURPOSES; INDUSTRIAL
`GASES; CATALYSTS; SOLVENTS; DYES FOR TEXTILE FABRICS; DISIN-
`FECTANTS; PREPARATIONS FORKILLING WEEDS AND DESTROYING
`VERMIN; INSECTICIDES; PESTICIDES; FUNGICIDES; BACTERICIDES;
`GERMICIDES; EXTINGUISHING COMPOSITIONS; TANNING SUBSTANCES;
`BLEACHING PREPARATIONS; EMULSIFYING AGENTS FOR USEIN IN-
`DUSTRY; TEXTILE AND FINISHING DRESSING PREPARATIONS; AND SYN-
`THETIC ORGANICSURFACE ACTIVE PURIFYING AND WETTING AGENTS;
`CHEMICAL SUBSTANCES FOR PRESERVINGFOODSTUFFS
`Class 002. First use: First Use: Mar 1926 First Use In Commerce: Nov 1926
`PAINTS, VARNISHES, ENAMELS, LACQUERS, DISTEMPERS, AND PRIMING
`PREPARATIONS
`Class 004. First use: First Use: Oct 1908 First Use In Commerce: Apr 1924
`INDUSTRIAL OILS AND GREASES, LUBRICANTS, FUELS, CANDLES, AND
`TAPERS
`Class 005. First use: First Use: Oct 1955 First Use In Commerce: Jun 1956
`PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND ANTISEPTICS
`FOR HUMAN AND VETERINARY USE
`Class 006. First use: First Use: Oct 1908 First Use In Commerce: May 1924
`
`

`

`[ METALS AND METAL ALLOYS]
`Class 011. First use: First Use: Oct 1908 First Use In Commerce: Sep 1924
`[ FILTER MATERIALS-NAMELY, FILTER PLATES AND SINTERED AND POR-
`OUS CERAMIC PRODUCTS ]
`Class 031. First use: First Use: May 1926 First Use In Commerce: Oct 1926
`[ SOILS ]
`
`U.S. registration
`no.
`Register
`Registration date
`
`4639815
`
`Principal
`11/18/2014
`
`Word mark
`Design mark
`
`LONZA
`
`Application date
`
`12/09/2013
`
`Foreign priority
`date
`
`NONE
`
`Description of
`mark
`Goods/services
`
`The mark consists of the word" LONZA" in block lettering.
`
`Class 001. First use: First Use: Jan 2003 First Use In Commerce: Jan 2003
`chemicals for use in industry and science; chemicals for use in agriculture, horti-
`culture and forestry, except fungicides, herbicides, insecticides and parasiti-
`cides; unprocessed artificial resins; unprocessed plastics; manures; tempering
`preparations and soldering chemicals andfluxes; chemical substances for pre-
`serving foodstuffs; tanning agents for use in the manufacture of leather; adhes-
`ives used in industry; inorganic and organic salts, namely, carnitine salts and l-
`carnitine salts; acids, namely, protein andnucleic acids for detection purposes
`other than for medical and veterinary purposes, docosahexaenoic acids, omega-
`3 fatty acids and derivatives thereof, carboxylic acid, halogenated fatty acids for
`industrial, manufacturing, or chemical use, and hydroxyacids; saturated and un-
`saturated aliphatic hydrocarbons; paraffin;aromatic hydrocarbons; organic oxy-
`gen compounds, namely, monovalent and multivalent alcoholates, esters,
`ketones, aldehydes, ethers, anhydrides, and keto compounds; nitrogen com-
`pounds, namely, nitrides, nitriles, amines, and amides; cycliccompounds,
`namely, heterocyclic compounds and compounds containing het-
`eroatoms;carbides; oxides; silicides; borides; phosphates; phosphines; silicates;
`inorganic compounds containing halogen and sulphur; catalysts for chemical
`and biochemical processes; aromatic solvents for industrial and commercial use;
`fire extinguishing and fire retardant compositions;bleaching preparations for in-
`dustrial purposes; surface active compounds for general use in the industrial
`arts, namely, emulsifying agents; wetting agents; chemical compound for use as
`an antimicrobial agent in the manufacture of household, institutional and indus-
`trial cleaners, deodorizers, water based paints and stains, and hydraulic fluids;
`chemical compounds and additives for use in the manufacture of wood preser-
`vatives; chemicalsfor the treatment of wood, namely, chemicals for the preven-
`tion of sap stain; chemical compounds for use in the manufacturing of household
`and industrial disinfectants and sanitizers; carnitine and its salts and derivates
`for use in the production of pharmaceutical preparations,dietetic substances and
`foodstuffs; chemical preparations and reagents for scientific purposes, namely,
`isolated human and animal cells cryopreserved and in culture for research pur-
`poses; diagnostic reagents for biological and pharmaceutical research and
`chemical reagents for non-medical purposes, namely, the manufacture of phar-
`maceutical products; endotoxin detection products, namely, assays andreagents
`
`

`

`for use in pharmaceutical and biotech research; diagnostic reagents for clinical
`or medical laboratory use; electrophoresis supplies, namely, nucleic acid stains,
`DNA markers, and loading buffers for non-medical use, electrophoresis gels oth-
`er than for medical or veterinary purposes; active chemical ingredients for use in
`the manufacture of personal care products, namely, hair and skin moisturizing
`and conditioning agents; chemicals for the treatment of water and wastewater;
`water treatment chemicals for use in swimming pools and spas
`Class 002. First use: First Use: Jan 2003 First Use In Commerce: Jan 2003
`dyes for textile fabrics; paints; varnishes; lacquers; preservatives against rust in
`the nature of a coating; anti-corrosive and anti-fouling compositions, namely,
`paints and coatings; anti-corrosiveoils; chemical wood preservatives to prevent
`decay, deterioration, insect damage and rot; wood preservatives; colorants; raw
`natural resins; wood stains; enamel paints; distempers; priming preparations
`and base coats, namely, paints; coating preparations having water repellant
`properties; waterproof paints; coatings for wood as paints
`Class 005. First use: First Use: Jan 2003 First Use In Commerce: Jan 2003
`antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical
`and veterinary preparations for the treatment of genetic malfunction in gene
`therapy, viral and infectious diseases, cardiovascular diseases, lung diseases,
`neurological diseases, and cancer; sanitary preparations for medical purposes;
`dietetic food and substances adapted for medical or veterinary use; food for ba-
`bies; dietary supplements for humans and animals; medical plasters; bandages
`for dressings; medical dressings; all purpose disinfectants; disinfectants for hy-
`gienic and sanitary purposes; multi-purpose disinfectants for household, institu-
`tional and industrial use; antimicrobial preservatives for use in the manufacture
`of cosmetics and toiletries; preparations for destroying vermin; fungicides; herbi-
`cides; preparations for killing weeds; insecticides; pesticides; bactericides;
`germicides; algaecides; preparations for destroying snails and mollusks; cell cul-
`turemedia for medical or clinical use and for scientific research, namely, for cul-
`tivating human cells, animal cells, and plant cells; antitoxic sera; sera and re-
`agents for biological and pharmaceutical research and for the manufacture of
`pharmaceutical products; serum-free cell growth media for medical or clinical
`use; cell culture reagents for medical or clinical use; endotoxin detection assays
`andreagents for medical or clinical use; deodorizers and sanitizers for industria-
`land household use; l-carnitine, salts, and derivatives thereof for pharmaceutical
`use, namely, for the treatment or prevention of cardiovascular diseases, cancer
`diseases, kidney diseases, diseases and disorders of fat and glucose metabol-
`ism, primary and secondary l-carnitine deficiency, male infertility, mental and
`cognitive diseases, liver diseases, HIV and AIDS, trauma and sepsis, malnutri-
`tion, aging and bone loss, or as ingredientsof pharmaceutical preparations; l-
`carnitine, salts and derivatives thereof as dietetic substances adapted for medic-
`al use and foodstuffs for medical use; dietary supplements and preparations for
`treating colds; algaecides, bactericides andvirucides for use in recirculating wa-
`ter systems, swimming pools and spas; antiseptics for human and veterinary
`use
`
`U.S. registration
`no.
`Register
`Registration date
`
`4483125
`
`Principal
`02/18/2014
`
`Word mark
`
`LONZA
`
`Application date
`
`02/14/2013
`
`Foreign priority
`date
`
`10/16/2012
`
`

`

`Design mark
`
`Description of
`mark
`Goods/services
`
`NONE
`
`Class 009. First use: First Use: None First Use In Commerce: None
`Computer software that provides web-based access to manufacturing opera-
`tions and testing data through a portal interface all focused on automation,
`namely, environmental monitoring, utility testing, and product testing; computer
`hardware and software systems for data capture, collection, labeling and testing
`in the field of life sciences; data processors and computers; computer peripher-
`als; computer programs and software recorded on data media designed for use
`in controllingof scientific apparatus and instrumentsfor the transfer of biological
`molecules into living cells, integration of foreign nucleic acids into the genome of
`living cells and transient production of proteins; computer software and hard-
`ware for mobile collection of sample and testing data in the pharmaceutical, food
`safety, environmental, forensics, and consumer products industries; computer
`software for providing an on-line database in the field of transaction processing
`to upload transactional data, provide statistical analysis, and produce notifica-
`tionsand reports
`Class 035. First use: First Use: None First Use In Commerce: None
`Business consulting, management, planning and supervision; business manage-
`ment consulting and advisory services, business management and enterprise
`organization consultancy; business strategic planning services, providing busi-
`ness management information in connection with consulting and advisory ser-
`vices in the field of strategic planning; development of marketing strategies and
`concepts; business management consultancy as well as development of pro-
`cesses for the analysis and the implementation of strategy plans and manage-
`ment projects; consultation services, namely, creative and strategic consultation
`regarding development and production of marketing campaigns for others; mar-
`keting plan development; planning,design, development, maintenance, tracking
`and reporting of online marketing activities for others; project management ser-
`vices for others for business purposes; business consultation services, namely,
`administrative process improvement
`Class 042. First use: First Use: None First Use In Commerce: None
`Pharmaceutical drug development services; pharmaceutical research and devel-
`opment; scientific laboratory services; scientific and technological services,
`namely, biological research and analysis; research and research services in the
`fieldof the transfer of biological moleculesinto living cells, integration of foreign
`nucleic acids into the genome of living cells and transient expression of proteins;
`scientific research services for others in the field of biochemistry; design and de-
`velopment of computer hardwareand software; development and research of
`new products for others; product development for others; product development
`consultation; product research and development; information technology con-
`sulting services; computer software consulting; consulting services in the fields
`of selection, implementation and use of computer hardware and software sys-
`tems for others
`
`U.S. registration
`no.
`Register
`Registration date
`
`5222498
`
`Principal
`06/13/2017
`
`Application date
`
`11/03/2016
`
`Foreign priority
`date
`
`NONE
`
`

`

`Word mark
`Design mark
`Description of
`mark
`Goods/services
`
`LONZA
`
`The mark consists of the word "LONZA" in block lettering.
`
`Class 040. First use: First Use: Jan 2003 First Use In Commerce: Jan 2003
`Custom manufacturing services for others for personal care products, hygiene
`and preservation products, nutritional products for humans and animals, phar-
`maceutical products, agricultural products, residential and industrial water treat-
`mentproducts, industrial wood protection products, industrial coatings, adhes-
`ives, sealants, lubricants and anticorrosion products, antimicrobial products for
`industrial, institutional and household uses, and chemical and biochemical
`products for scientific use
`Class 042. First use: First Use: Jan 2003 First Use In Commerce: Jan 2003
`Product research and development; scientific research and development; re-
`searchand development in the field of microorganisms and cells
`
`U.S. registration
`no.
`Register
`Registration date
`
`4922144
`
`Principal
`03/22/2016
`
`Application date
`
`06/16/2015
`
`Foreign priority
`date
`
`NONE
`
`Word mark
`Design mark
`Description of
`mark
`Goods/services
`
`LONZA
`
`NONE
`
`Class 040. First use: First Use: Apr 1, 2001 First Use In Commerce: Apr 1, 2001
`custom production and processing of chemicals, ingredients for pharmaceutic-
`als,and cells for research and scientific purposes for others; Manufacture of bac-
`teriological cultures, buffer solution, and reagents to the order and specification
`of others
`Class 041. First use: First Use: 2010 First Use In Commerce: 2010
`providing instruction in the manufacture of pharmaceuticals, cell cultures, andlife
`science research; educational services, namely, provided classes, seminars,
`and workshops in the field of the manufacture of pharmaceuticals, cell cultures,
`and life science research; Arranging,conducting and organization of seminarsin
`the field of the manufacture of pharmaceuticals, cell cultures, and life science re-
`search; Providing non-downloadable electronic publications in the nature of art-
`icles in the field of the manufacture of pharmaceuticals, cell cultures, and life sci-
`ence research; reference libraries of literature and documentary records
`Class 042. First use: First Use: Apr 1, 2001 First Use In Commerce: Apr 1, 2001
`product research and development; scientific research and development; Re-
`searchand development in the field of microorganisms and cells
`
`U.S. registration
`no.
`Register
`Registration date
`
`6432082
`
`Principal
`07/27/2021
`
`Word mark
`
`LONZA
`
`Application date
`
`09/23/2020
`
`Foreign priority
`date
`
`NONE
`
`

`

`Design mark
`
`Description of
`mark
`Goods/services
`
`NONE
`
`Class 009. First use: First Use: Aug 10, 2016 First Use In Commerce: Aug 10,
`2016
`Equipment for manufacturing autologous cell therapies comprising bioreactors
`for cell culturing with disposable units
`
`Attachments
`
`86138751#TMSN.png( bytes )
`79128068#TMSN.png( bytes )
`90203609#TMSN.png( bytes )
`125700.EVIDENCE.Notice.of.Opposition.pdf(210530 bytes )
`125700.EVIDENCE.Exhibit 1.pdf(200095 bytes )
`
`Signature
`Name
`Date
`
`/Allyson M. Martin/
`Allyson M. Martin
`06/22/2022
`
`

`

`
`
`5335.125700
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`)
`
`
`In the Matter of Application Serial No.:
`)
`
`
`
`87404854
`
`
`
`)
`
`
`
`For the mark – LONZOR
`
`)
`
`
`
`
`
`
`
`
`)
`
`
`
`
`
`
`
`
`)
`
`
`Lonza Ltd.,
`
`
`
`
`)
`
`
`
`
`
`
`
`
`)
`
`
`
`
`
`Opposer,
`
`)
`
`
`
`
`v.
`
`
`
`)
`
`
`
`
`
`
`
`
`)
`
`
`Novartis AG,
`
`
`
`)
`
`
`
`
`
`
`
`
`)
`
`
`
`
`
`Applicant.
`
`
`
`
`
`
`
`
`
`NOTICE OF OPPOSITION
`
`
`Box TTAB
`Commissioner for Trademarks
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
`Dear Sir:
`
`
`
`The above-identified Opposer believes that it will be damaged by the registration of the
`
`application identified above, and hereby opposes the same.
`
`
`
`The grounds for opposition, the Opposer alleges that:
`
`1.
`
`Opposer, Lonza Ltd. (“Opposer”), is a corporation organized under the laws of
`
`Switzerland and having a principal place of business at Lonzastrasse, Visp, 3930, Switzerland.
`
`2.
`
`Upon information and belief, Applicant, Novartis AG (“Applicant”), is a
`
`corporation organized under the laws of Switzerland, and having a principal place of business at
`
`CH-4002, Basel, Switzerland.
`
`
`
`1
`
`

`

`
`
`3.
`
`On April 10, 2017, Applicant filed a Trademark Application to register the mark
`
`LONZOR in International Class 005 for “Anti-infectives; Anti-inflammatories; Antibacterial
`
`pharmaceuticals; Antibiotics; Antifungal
`
`preparations; Antivirals; Cardiovascular
`
`pharmaceuticals; Dermatological pharmaceutical products;
`
`Inhaled pharmaceutical
`
`preparations for the prevention and treatment of respiratory diseases and disorders;
`
`Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations
`
`and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical
`
`preparations for the prevention and treatment of diseases and disorders of the autoimmune system,
`
`the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary
`
`system; Pharmaceutical preparations for use in hematology and in tissue and organ
`
`transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases
`
`and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm
`
`disorders; Pharmaceutical preparations for the prevention and treatment of immune system
`
`related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of
`
`kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes;
`
`Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical
`
`preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for
`
`use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products
`
`for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer
`
`and tumors; Pharmaceutical preparations for the prevention and treatment of allergies;
`
`Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical
`
`products for the prevention and treatment of respiratory diseases and asthma,” U.S. Application
`
`
`
`2
`
`

`

`
`
`Ser. No. 87/404,854 based on Intent to Use, which was published for opposition on May 24, 2022
`
`(the “LONZOR Mark”).
`
`4.
`
`At least as early as 1897, Opposer adopted the trademark LONZA for
`
`pharmaceutical and medicinal preparations. Since that time, Opposer has continuously used the
`
`LONZA trademark in connection with pharmaceutical and medicinal preparations.
`
`5.
`
`Opposer has incorporated the LONZA Mark as part of its company name and is
`
`one of the world’s leading suppliers to the pharmaceutical and biotechnology market.
`
`6.
`
`Opposer adopted and continuously uses the LONZA Mark for a wide range of
`
`goods and services, including but not limited to, pharmaceutical and medicinal preparations and
`
`various chemical substances.
`
`7.
`
`Opposer is the owner of the below U.S. Trademark Registrations. True and correct
`
`copies of Opposer’s registration details are attached as Exhibit 1.
`
`Mark
`Reg. Date
`Reg. No.
`0,956,300 April 3, 1973 LONZA
`
`
`
`3
`
`Goods and Services
`IC 001: adhesive substances used in
`industry; inorganic and organic salts;
`acids; bases; saturated and unsaturated
`aliphatic
`hydrocarbons;
`paraffines;
`aromatic hydrocarbons; organic oxygen
`compounds such as monovalent and
`multivalent alcoholates, esters, ketones,
`aldehydes, ethers, carboxylic acids,
`anhydrides,
`hydroxyacids,
`keto
`compounds, halogenated
`fatty acids,
`organic nitrogen compounds, nitriles,
`amines, amides, nitro compounds, cyclic
`compounds, heterocyclic compounds, and
`compounds
`containing
`heteroatoms,
`organo metalic compounds, inorganic
`compounds, carbides, nitrides, oxides,
`silicides,
`borides,
`phosphates,
`phosphines, silicates, inorganic products
`containing halogen and sulphur; inorganic
`starting,
`intermediate,
`or
`auxiliary
`products
`for chemical and ceramic
`
`

`

`
`
`
`
`industrial gases; catalysts;
`purposes;
`solvents; dyes
`for
`textile
`fabrics;
`disinfectants; preparations for killing
`weeds
`and
`destroying
`vermin;
`insecticides;
`pesticides;
`fungicides;
`bactericides; germicides; extinguishing
`compositions;
`tanning
`substances;
`bleaching
`preparations;
`emulsifying
`agents for use in industry; textile and
`finishing dressing preparations; and
`synthetic organic surface active purifying
`and wetting agents; chemical substances
`for preserving foodstuffs
`
`IC 002: paints, varnishes, enamels,
`lacquers,
`distempers,
`and
`priming
`preparations
`
`IC 004: paints, varnishes, enamels,
`lacquers,
`distempers,
`and
`priming
`preparations
`
`IC 005: pharmaceutical and medicinal
`preparations and antiseptics for human
`and veterinary use
`IC 001: chemicals for use in industry and
`science; chemicals for use in agriculture,
`horticulture
`and
`forestry,
`except
`fungicides, herbicides, insecticides and
`parasiticides;
`unprocessed
`artificial
`resins; unprocessed plastics; manures;
`tempering preparations and soldering
`chemicals
`and
`fluxes;
`chemical
`substances for preserving foodstuffs;
`tanning agents for use in the manufacture
`of leather; adhesives used in industry;
`inorganic and organic salts, namely,
`carnitine salts and l-carnitine salts; acids,
`namely, protein and nucleic acids for
`detection purposes other than for medical
`and veterinary purposes, docosahexaenoic
`acids, omega-3 fatty acids and derivatives
`thereof, carboxylic acid, halogenated fatty
`acids for industrial, manufacturing, or
`chemical use, and hydroxyacids; saturated
`and unsaturated aliphatic hydrocarbons;
`
`4,639,815 Nov. 18, 2014
`
`
`
`4
`
`

`

`
`
`
`
`paraffin; aromatic hydrocarbons; organic
`oxygen compounds, namely, monovalent
`and multivalent
`alcoholates,
`esters,
`ketones, aldehydes, ethers, anhydrides,
`and
`keto
`compounds;
`nitrogen
`compounds, namely, nitrides, nitriles,
`amines, and amides; cyclic compounds,
`namely, heterocyclic compounds and
`compounds
`containing
`heteroatoms;
`carbides; oxides;
`silicides; borides;
`phosphates;
`phosphines;
`silicates;
`inorganic compounds containing halogen
`and sulphur; catalysts for chemical and
`biochemical processes; aromatic solvents
`for industrial and commercial use; fire
`extinguishing
`and
`fire
`retardant
`compositions; bleaching preparations for
`industrial
`purposes;
`surface
`active
`compounds
`for general use
`in
`the
`industrial arts, namely, emulsifying
`agents; wetting
`agents;
`chemical
`compound for use as an antimicrobial
`agent in the manufacture of household,
`institutional and
`industrial cleaners,
`deodorizers, water based paints and stains,
`and
`hydraulic
`fluids;
`chemical
`compounds and additives for use in the
`manufacture of wood preservatives;
`chemicals for the treatment of wood,
`namely, chemicals for the prevention of
`sap stain; chemical compounds for use in
`the manufacturing of household and
`industrial disinfectants and sanitizers;
`carnitine and its salts and derivates for use
`in
`the production of pharmaceutical
`preparations, dietetic substances and
`foodstuffs; chemical preparations and
`reagents for scientific purposes, namely,
`isolated human
`and
`animal
`cells
`cryopreserved and in culture for research
`purposes;
`diagnostic
`reagents
`for
`biological and pharmaceutical research
`and chemical reagents for non-medical
`purposes, namely, the manufacture of
`pharmaceutical
`products;
`endotoxin
`detection products, namely, assays and
`
`5
`
`

`

`
`
`
`
`reagents for use in pharmaceutical and
`biotech research; diagnostic reagents for
`clinical or medical
`laboratory use;
`electrophoresis supplies, namely, nucleic
`acid stains, DNA markers, and loading
`buffers
`for
`non-medical
`use,
`electrophoresis gels other than for medical
`or veterinary purposes; active chemical
`ingredients for use in the manufacture of
`personal care products, namely, hair and
`skin moisturizing
`and
`conditioning
`agents; chemicals for the treatment of
`water and wastewater; water treatment
`chemicals for use in swimming pools and
`spa
`
`IC 002: dyes for textile fabrics; paints;
`varnishes; lacquers; preservatives against
`rust in the nature of a coating; anti-
`corrosive and anti-fouling compositions,
`namely, paints and coatings; anti-
`corrosive
`oils;
`chemical
`wood
`preservatives
`to
`prevent
`decay,
`deterioration, insect damage and rot;
`wood preservatives;
`colorants;
`raw
`natural resins; wood stains; enamel paints;
`distempers; priming preparations and base
`coats,
`namely,
`paints;
`coating
`preparations having water
`repellant
`properties; waterproof paints; coatings for
`wood as paints
`
`IC 005: antimicrobial preservatives for
`cosmetics
`and
`pharmaceuticals;
`pharmaceutical
`and
`veterinary
`preparations for the treatment of genetic
`malfunction in gene therapy, viral and
`infectious
`diseases,
`cardiovascular
`diseases,
`lung diseases, neurological
`diseases, and cancer; sanitary preparations
`for medical purposes; dietetic food and
`substances adapted
`for medical or
`veterinary use; food for babies; dietary
`supplements for humans and animals;
`medical plasters; bandages for dressings;
`all
`purpose
`dressings;
`medical
`
`6
`
`

`

`
`
`
`
`4,483,125
`
`Feb. 18, 2014 LONZA
`
`7
`
`disinfectants; disinfectants for hygienic
`and sanitary purposes; multi-purpose
`disinfectants for household, institutional
`and
`industrial
`use;
`antimicrobial
`preservatives for use in the manufacture
`of cosmetics and toiletries; preparations
`for
`destroying
`vermin;
`fungicides;
`herbicides; preparations for killing weeds;
`insecticides;
`pesticides;
`bactericides;
`germicides; algaecides; preparations for
`destroying snails and mollusks; cell
`culture media for medical or clinical use
`and for scientific research, namely, for
`cultivating human cells, animal cells, and
`plant cells; antitoxic sera; sera and
`reagents
`for
`biological
`and
`pharmaceutical research and for
`the
`manufacture of pharmaceutical products;
`serum-free cell growth media for medical
`or clinical use; cell culture reagents for
`medical or clinical use; endotoxin
`detection assays and reagents for medical
`or clinical use; deodorizers and sanitizers
`for industrial and household use; l-
`carnitine, salts, and derivatives thereof for
`pharmaceutical use, namely, for
`the
`treatment or prevention of cardiovascular
`diseases, cancer diseases, kidney diseases,
`diseases and disorders of fat and glucose
`metabolism, primary and secondary l-
`carnitine deficiency, male
`infertility,
`mental and cognitive diseases,
`liver
`diseases, HIV and AIDS, trauma and
`sepsis, malnutrition, aging and bone loss,
`or as
`ingredients of pharmaceutical
`preparations;
`l-carnitine,
`salts
`and
`derivatives thereof as dietetic substances
`adapted for medical use and foodstuffs for
`medical use; dietary supplements and
`preparations for treating colds; algaecides,
`bactericides and virucides for use in
`recirculating water systems, swimming
`pools and spas; antiseptics for human and
`veterinary use
`IC 009: Computer software that provides
`web-based access
`to manufacturing
`
`

`

`
`
`
`
`operations and testing data through a
`portal interface all focused on automation,
`namely, environmental monitoring, utility
`testing, and product testing; computer
`hardware and software systems for data
`capture, collection, labeling and testing in
`the field of life sciences; data processors
`and computers; computer peripherals;
`computer programs and software recorded
`on data media designed for use in
`controlling of scientific apparatus and
`instruments for the transfer of biological
`molecules into living cells, integration of
`foreign nucleic acids into the genome of
`living cells and transient production of
`proteins; computer software and hardware
`for mobile collection of sample and
`testing data in the pharmaceutical, food
`safety, environmental,
`forensics, and
`consumer products industries; computer
`software for providing an on-line database
`in the field of transaction processing to
`upload
`transactional
`data,
`provide
`statistical
`analysis,
`and
`produce
`notifications and reports
`
`consulting,
`Business
`035:
`IC
`management, planning and supervision;
`business management consulting and
`advisory services, business management
`and enterprise organization consultancy;
`business strategic planning services,
`providing
`business
`management
`information in connection with consulting
`and advisory services in the field of
`strategic planning; development of
`marketing
`strategies
`and
`concepts;
`business management consultancy as well
`as development of processes for the
`analysis and
`the
`implementation of
`strategy plans and management projects;
`consultation services, namely, creative
`and
`strategic consultation
`regarding
`development and production of marketing
`campaigns for others; marketing plan
`design,
`planning,
`development;
`
`8
`
`

`

`
`
`
`
`development, maintenance, tracking and
`reporting of online marketing activities
`for others; project management services
`for others for business purposes; business
`consultation
`services,
`namely,
`administrative process improvement
`
`IC 042